Sign In
Buy XPH
$56.32
+0.615 (+1.10%)
At Close: Jun 03, 2026
XPH: Healthcare Dashboard For July
05:13pm, Tuesday, 15'th Jul 2025
This article provides a top-down view of the healthcare sector based on valuation and quality metrics. Healthcare providers are the most undervalued subsector, while pharma/biotech has the best qualit
ETFs on the Move Post U.S.-China Trade Deal
01:55pm, Monday, 12'th May 2025
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
A Look at Pharma ETFs After Strong Q1 Earnings
12:50pm, Thursday, 08'th May 2025
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Pharma ETFs in Focus Post Solid Q2 Earnings
12:51pm, Wednesday, 14'th Aug 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:21am, Wednesday, 24'th Jul 2024
The SPDR S&P Pharmaceuticals ETF (XPH) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:20am, Wednesday, 17'th Jul 2024
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
Finding Opportunity in Unloved Healthcare ETFs
11:02am, Friday, 31'st May 2024
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:20am, Thursday, 16'th May 2024
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaround
09:01am, Tuesday, 14'th May 2024
We have highlighted five ETFs from different zones that have plunged the most so far this year but have a solid Zacks ETF Rank.
A Look at Pharma ETFs Post Q1 Earnings
12:31pm, Tuesday, 07'th May 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
XPH: A More Balanced Way To Get Exposure To Pharmaceuticals
10:38am, Thursday, 28'th Mar 2024
The SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. pharmaceuticals sector, making it a good option for investing in the industry. XPH tracks the performance of the S&P Pharmaceut
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:21am, Thursday, 15'th Feb 2024
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:21am, Wednesday, 14'th Feb 2024
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:31am, Friday, 15'th Dec 2023
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
